UA95253U - A method for analgesic potentiation of peripheral genesis of carbamazepine - Google Patents

A method for analgesic potentiation of peripheral genesis of carbamazepine

Info

Publication number
UA95253U
UA95253U UAU201408577U UAU201408577U UA95253U UA 95253 U UA95253 U UA 95253U UA U201408577 U UAU201408577 U UA U201408577U UA U201408577 U UAU201408577 U UA U201408577U UA 95253 U UA95253 U UA 95253U
Authority
UA
Ukraine
Prior art keywords
carbamazepine
genesis
peripheral
analgesic potentiation
coffein
Prior art date
Application number
UAU201408577U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ганна Олегівна Сирова
Руслан Орестович Бачинський
Лариса Володимирівна Лук'янова
Віктор Сергійович Шапошник
Original Assignee
Харківський Національний Медичний Університет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківський Національний Медичний Університет filed Critical Харківський Національний Медичний Університет
Priority to UAU201408577U priority Critical patent/UA95253U/en
Publication of UA95253U publication Critical patent/UA95253U/en

Links

Abstract

A method for analgesic potentiation includes coffein addition. Coffein is added to carbamazepine at that there shall be used carbamazepine in the amount of 6,25 mg and 0,6 mg of coffein per 1 kg of an animal weight.
UAU201408577U 2014-07-28 2014-07-28 A method for analgesic potentiation of peripheral genesis of carbamazepine UA95253U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201408577U UA95253U (en) 2014-07-28 2014-07-28 A method for analgesic potentiation of peripheral genesis of carbamazepine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201408577U UA95253U (en) 2014-07-28 2014-07-28 A method for analgesic potentiation of peripheral genesis of carbamazepine

Publications (1)

Publication Number Publication Date
UA95253U true UA95253U (en) 2014-12-10

Family

ID=52681442

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201408577U UA95253U (en) 2014-07-28 2014-07-28 A method for analgesic potentiation of peripheral genesis of carbamazepine

Country Status (1)

Country Link
UA (1) UA95253U (en)

Similar Documents

Publication Publication Date Title
ZA201608077B (en) Combination, composition, and method of administering the combination or composition to animals
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
MX2015009106A (en) Solid solution compositions and use in severe pain.
MX2017006208A (en) Modular portable ballet bar exercise device.
MX2019010594A (en) Beta-casein a2 and prevention of inflammation of the bowel.
MX369357B (en) Antifungal compound process.
MX365494B (en) Antifungal compound process.
MX2017005484A (en) Dopamine d3 receptor antagonists compounds.
MX2017006709A (en) Agent for preventing or improving symptoms caused by imbalance of sex hormones.
PH12017500348A1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
SG11201701476PA (en) Composition for reducing local fat and body weight, and pharmaceuticals and use thereof
PH12016502530A1 (en) Pharmaceutical compositions comprising dgla and use of same
MY175326A (en) Product and method for treating diarrhea
PH12016502311A1 (en) Omega-3 analogues
ZA201703214B (en) Feeding algae to cattle at low doses to produce high omega 3 levels in beef
PH12017500923A1 (en) New dosage and use of a a2a antagonist
UA95253U (en) A method for analgesic potentiation of peripheral genesis of carbamazepine
UA95254U (en) A method for analgesic action enhancement of paracetamol peripheral genesis
UA106905U (en) Pharmaceutical formulation
EP3167884A4 (en) 2h-chromene derivatives as analgesic agents
TH1601000678A (en) Complementary active ingredients for use as oxygen binders and as a corrosion inhibitor in the AQUIS system.
PT3862003T (en) An sglt-2 inhibitor for use in the treatment of a metabolic disorder in feline animals
PH12014000104A1 (en) Therapeutic methods and compositions for treating diabetes
CN302046483S (en) Bark Stopper (FET851)